Paediatric scientific guidelines

  • Email
  • Help

The Committee for Medicinal Products for Human Use (CHMP) draws up scientific guidelines aimed at helping applicants prepare marketing-authorisation applications for medicinal products for human use.

Below are the titles of scientific guidelines, reflection papers and concept papers relevant to the development of medicines for children (the list is non-exhaustive).

A complete register of all scientific guidance published online by the European Medicines Agency is available.

Table of contents


Quality guidelines

Back to top

Non-clinical guidelines

Back to top

Document(s) Language Status First published Last updated Effective Date
Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications (English only) adopted 24/01/2008   01/08/2008

Clinical efficacy and safety guidelines

Back to top

Document(s) Language Status First published Last updated Effective Date
ICH: E 11: Clinical investigation of medicinal products in the paediatric population - Step 5 (English only) adopted 01/01/2001   01/01/2001
Guideline on the role of pharmacokinetics in the development of medicinal products in the paediatric population (English only) adopted 28/06/2006   01/01/2007
Guideline on clinical trials in small populations (English only) adopted 27/07/2006   01/02/2007
Guideline on conduct of pharmacovigilance for medicines used by the paediatric population (English only) adopted 25/01/2007   26/01/2007
Note for guidance on evaluation of anticancer medicinal products on man: Addendum on paediatric oncology (English only) adopted 24/07/2003   01/01/2004

Multidisciplinary (paediatrics)

Back to top

Related links